| Literature DB >> 31028352 |
H Selcuk Ozger1, Tugba Cuhadar2, Serap Suzuk Yildiz3,4, Zehra Demirbas Gulmez5, Murat Dizbay5, Ozlem Guzel Tunccan5, Ayşe Kalkanci2, Husniye Simsek3, Ozlem Unaldi4.
Abstract
The synergistic activity of eravacycline in combination with colistin on carbapenem-resistant A. baumannii (CRAB) isolates was evaluated in this study. Minimum inhibitory concentrations (MICs) of eravacycline and colistin were determined by the broth microdilution method. MICs values ranged between 1 to 4 mg and 0.5 to 256 mg l-1 for eravacycline and colistin, respectively. In vitro synergy between eravacycline and colistin was evaluated by using the chequerboard methodology. Synergistic activity was found in 10% of the strains, and additive effect in 30%. No antagonism was detected. Similar activity was also observed in colistin-resistant CRAB isolates. The result of this study indicates that eravacycline and colistin combination may be a potential therapeutic option for the treatment of CRAB related infections.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31028352 DOI: 10.1038/s41429-019-0188-6
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649